TEGEAN CAPITAL MANAGEMENT, LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 2 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
TEGEAN CAPITAL MANAGEMENT, LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$814
-59.3%
45,7100.0%0.00%
-83.3%
Q3 2022$2,002
-50.0%
45,710
-33.3%
0.01%
+50.0%
Q2 2022$4,002
-60.0%
68,565
+50.0%
0.00%
-20.0%
Q1 2022$10,000
-58.3%
45,7100.0%0.01%
-58.3%
Q4 2021$24,000–45,710–0.01%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2023
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 9,800$108,0540.10%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders